LAVA THERAPEUTICS NV (LVTX) Stock Analyst Earnings Estimates
NASDAQ:LVTX - Nasdaq - NL0015000AG6 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.39M 287.80% | 6.769M -65.09% | 11.982M 77.01% | -100.00% | 2.957M | 11.822M 299.80% | 18.473M 56.26% | |||||
| EBITDA YoY % growth | -34.06M 22.22% | -42.782M -25.61% | -29.226M 31.69% | -33.253M -13.78% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.84M 21.44% | -43.394M -24.55% | -29.693M 31.57% | -34.929M -17.63% | -33.809M 3.21% | -34.485M -2.00% | -21.181M 38.58% | -21.708M -2.49% | -14.043M 35.31% | -5.215M 62.86% | 765.961K 114.69% | |
| Operating Margin | -179.68% | -641.07% | -247.81% | N/A | N/A | N/A | N/A | N/A | -474.89% | -44.11% | 4.15% | |
| EPS YoY % growth | -1.25 88.76% | -1.59 -27.21% | -0.93 41.51% | -1.17 -25.40% | -0.72 38.48% | -0.38 47.39% | -0.25 32.51% | -0.25 | -0.07 71.89% | 0.10 241.31% | 0.21 111.29% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 15.55% | -0.26 44.57% | -0.26 -82.14% | -0.24 -88.31% |
| Revenue Q2Q % growth | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.582M 19.00% | -7.436M 34.10% | -7.304M 75.40% | -8.054M -6.14% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.13 -550.00% | -0.39 | 0.26 | 66.68% |
| Q4 2024 Q2Q % growth | -0.14 41.67% | -0.30 | 0.16 | 53.47% |
| Q3 2024 Q2Q % growth | -0.46 -35.29% | -0.34 | -0.12 | -36.66% |
| Q2 2024 Q2Q % growth | -0.31 35.42% | -0.37 | 0.06 | 15.58% |
| Q1 2024 Q2Q % growth | -0.02 96.23% | -0.13 | 0.11 | 84.31% |
| Q4 2023 Q2Q % growth | -0.24 57.89% | -0.13 | -0.11 | -88.24% |
| Q3 2023 Q2Q % growth | -0.34 -944.72% | -0.50 | 0.16 | 31.97% |
| Q2 2023 Q2Q % growth | -0.48 -54.92% | -0.48 | 0.00 | 0.58% |
| Q1 2023 Q2Q % growth | -0.53 -29.16% | -0.53 | 0.00 | 0.08% |
| Q4 2022 Q2Q % growth | -0.57 -50.21% | -0.65 | 0.08 | 11.83% |
| Q3 2022 Q2Q % growth | 0.04 114.85% | -0.14 | 0.18 | 128.69% |
| Q2 2022 Q2Q % growth | -0.31 -11.86% | -0.64 | 0.33 | 51.88% |
| Q1 2022 Q2Q % growth | -0.41 95.97% | -0.88 | 0.47 | 53.28% |
| Q4 2021 Q2Q % growth | -0.38 | -0.41 | 0.04 | 8.50% |
| Q3 2021 Q2Q % growth | -0.27 | -0.32 | 0.05 | 15.00% |
| Q2 2021 Q2Q % growth | -0.28 | -0.28 | 0.00 | 1.22% |
| Q1 2021 Q2Q % growth | -10.19 | -0.68 | -9.51 | -1,394.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | 4.99M 1,313.60% | 2.55M | 2.44M | 95.69% |
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | 6.992M 471.24% | 7.14M | -148K | -2.07% |
| Q4 2023 Q2Q % growth | 353K -86.63% | 6.375M | -6.022M | -94.46% |
| Q3 2023 Q2Q % growth | 53K -99.65% | 53K | % | |
| Q2 2023 Q2Q % growth | 5.139M 993.40% | 849.997K | 4.289M | 504.59% |
| Q1 2023 Q2Q % growth | 1.224M 20.00% | 1.224M | % | |
| Q4 2022 Q2Q % growth | 2.64M -47.20% | 255K | 2.385M | 935.29% |
| Q3 2022 Q2Q % growth | 15.26M 626.67% | 10.265M | 4.995M | 48.66% |
| Q2 2022 Q2Q % growth | 470K -56.48% | 364.915K | 105.085K | 28.80% |
| Q1 2022 Q2Q % growth | 1.02M -8.11% | 552.197K | 467.803K | 84.72% |
| Q4 2021 Q2Q % growth | 5M 42.86% | 422.066K | 4.578M | 1,084.65% |
| Q2 2021 Q2Q % growth | 1.08M 66.15% | 1.08M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 32.01% | -2.69% | 25.27% |
| Revenue | N/A | N/A | N/A | N/A |